Related Experiment Videos
Idiopathic thrombocytopenic purpura in children
Insights
Idiopathic thrombocytopenic purpura (ITP) in children typically resolves spontaneously within a year. Conservative management is recommended, avoiding aspirin and trauma, as serious bleeding is rare.
Area of Science:
- Pediatrics
- Immunology
- Hematology
Background:
- Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disorder.
- Characterized by antibody-mediated destruction of platelets.
- Presents with isolated thrombocytopenia in children.
Purpose of the Study:
- To describe the clinical presentation and natural history of ITP in children.
- To outline appropriate management strategies for pediatric ITP.
- To evaluate the long-term prognosis of childhood ITP.
Main Methods:
- Review of clinical data for children diagnosed with ITP.
- Analysis of laboratory findings and physical examination results.
- Assessment of treatment outcomes and spontaneous recovery rates.
Main Results:
- Physical and laboratory examinations are typically normal except for thrombocytopenia.
- Excellent prognosis in children, with 90% spontaneous recovery within one year.
- Serious hemorrhage is uncommon.
Conclusions:
- Conservative management is appropriate for pediatric ITP.
- Avoidance of aspirin and potential trauma is advised.
- Corticosteroids may temporarily increase platelet count but do not alter the long-term outlook.
Abstract:
Idiopathic thrombocytopenic purpura is a disorder characterized by antibody-mediated platelet destruction. Other than thrombocytopenia and its consequences, the physical and laboratory examination of the child with ITP is normal. The prognosis in children is excellent; 90 percent will recover spontaneously within one year. Serious hemorrhage is uncommon and conservative management is appropriate. Aspirin and potential trauma should be avoided. Transfusions are rarely necessary or helpful. Corticosteroids may cause a more rapid rise in the platelet count but do not influence the long-term prognosis.